Heike Zeitler

Summary

Affiliation: University of Bonn
Country: Germany

Publications

  1. doi request reprint Long term outcome of patients with acquired haemophilia - A monocentre interim analysis of 82 patients
    H Zeitler
    Internal Medical Clinic I of the University of Bonn, Centre of Extracorporeal Therapy and Autoimmunity CETA, Sigmund Freud Str 27, 53127 Bonn, Germany Electronic address
    Atheroscler Suppl 14:223-8. 2013
  2. doi request reprint Multiple benign symmetric lipomatosis--a differential diagnosis of obesity. Is there a rationale for fibrate treatment?
    Heike Zeitler
    Centre of Extracorporeal Treatment and Lipid Disorders, Bonn, Germany
    Obes Surg 18:1354-6. 2008
  3. doi request reprint Immunoadsorption in the treatment of acquired haemophilia
    Heike Zeitler
    Internal Medical Clinic I of the University of Bonn, Centre of Extracorporeal Therapy and Autoimmunity, Germany
    Atheroscler Suppl 10:122-5. 2009
  4. doi request reprint The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients
    H Zeitler
    Internal Medical Clinic I of the University of Bonn, Centre of Extracorporeal Therapy and Autoimmunity CETA, Bonn, Germany
    Haemophilia 16:95-101. 2010
  5. doi request reprint Multiple benign symmetric lipomatosis--a differential diagnosis of obesity: is there a rationale for fibrate treatment?
    Zeitler Heike
    Centre of Extracorporeal Treatment and Lipid Disorders, Medical Policlinic, Bonn, Germany
    Obes Surg 18:240-2. 2008
  6. ncbi request reprint Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept
    Heike Zeitler
    Medical Policlinic, University of Bonn, Wilhelmstrasse 35 37, 53111 Bonn, Germany
    Blood 105:2287-93. 2005
  7. ncbi request reprint Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis
    Heike Zeitler
    Medical Policlinic, University of Bonn, Bonn, Germany
    Artif Organs 30:597-605. 2006
  8. ncbi request reprint Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins
    Gudrun Ulrich-Merzenich
    Medical Policlinic of the Friedrich Wilhelm University of Bonn, Wilhelmstrasse 35 37, 53111 Bonn, Germany
    Eur J Nutr 46:431-8. 2007
  9. ncbi request reprint Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway
    Gudrun Ulrich-Merzenich
    Medical Policlinic of the Rheinische, Friedrich Wilhelms University of Bonn, Wilhelmstr 35 37 53111 Bonn, Germany
    Eur J Nutr 46:87-94. 2007
  10. doi request reprint New perspectives for synergy research with the "omic"-technologies
    G Ulrich-Merzenich
    Medical Policlinic of the Rheinische Friedrich Wilhelms University of Bonn, Wilhelmstr 35 37, D 53111 Bonn, Germany
    Phytomedicine 16:495-508. 2009

Collaborators

Detail Information

Publications17

  1. doi request reprint Long term outcome of patients with acquired haemophilia - A monocentre interim analysis of 82 patients
    H Zeitler
    Internal Medical Clinic I of the University of Bonn, Centre of Extracorporeal Therapy and Autoimmunity CETA, Sigmund Freud Str 27, 53127 Bonn, Germany Electronic address
    Atheroscler Suppl 14:223-8. 2013
    ..9 and 22%. Due to the low incidence of AH, randomized studies are not available, but observational studies with a long term follow up are of high interest...
  2. doi request reprint Multiple benign symmetric lipomatosis--a differential diagnosis of obesity. Is there a rationale for fibrate treatment?
    Heike Zeitler
    Centre of Extracorporeal Treatment and Lipid Disorders, Bonn, Germany
    Obes Surg 18:1354-6. 2008
    ....
  3. doi request reprint Immunoadsorption in the treatment of acquired haemophilia
    Heike Zeitler
    Internal Medical Clinic I of the University of Bonn, Centre of Extracorporeal Therapy and Autoimmunity, Germany
    Atheroscler Suppl 10:122-5. 2009
    ..However, the severity of bleeding, and therefore the cost-effectiveness of the approach, needs to be considered when initiating this treatment protocol...
  4. doi request reprint The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients
    H Zeitler
    Internal Medical Clinic I of the University of Bonn, Centre of Extracorporeal Therapy and Autoimmunity CETA, Bonn, Germany
    Haemophilia 16:95-101. 2010
    ..Treatment procedures should be adapted to bleeding severity and inhibitor titres. Under these conditions, AH is a potentially curable autoimmune disorder with an excellent prognosis...
  5. doi request reprint Multiple benign symmetric lipomatosis--a differential diagnosis of obesity: is there a rationale for fibrate treatment?
    Zeitler Heike
    Centre of Extracorporeal Treatment and Lipid Disorders, Medical Policlinic, Bonn, Germany
    Obes Surg 18:240-2. 2008
    ..Fibrates, peroxisome proliferator-activated receptor alpha agonists, are pleiotropic hypolipidemic drugs and might have worked by suppression of protein expressions involved in the architecture of BAT keeping it in a quiescent state...
  6. ncbi request reprint Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept
    Heike Zeitler
    Medical Policlinic, University of Bonn, Wilhelmstrasse 35 37, 53111 Bonn, Germany
    Blood 105:2287-93. 2005
    ..Long-term follow-up (7 months-7 years) showed an overall response rate of 88% for complete remission (CR). When cancer patients were excluded, the CR rate was 97%...
  7. ncbi request reprint Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis
    Heike Zeitler
    Medical Policlinic, University of Bonn, Bonn, Germany
    Artif Organs 30:597-605. 2006
    ..4 years. No fatalities due to MC occurred. The results demonstrate that our protocol is a potent therapeutic approach in the treatment of MC...
  8. ncbi request reprint Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins
    Gudrun Ulrich-Merzenich
    Medical Policlinic of the Friedrich Wilhelm University of Bonn, Wilhelmstrasse 35 37, 53111 Bonn, Germany
    Eur J Nutr 46:431-8. 2007
    ..Endothelial dysfunction, common to diabetes and cardiovascular diseases, is an early step in the development of atherosclerosis and diabetic angiopathies. Deficiencies of taurine have been related to diabetes and cardiovascular diseases...
  9. ncbi request reprint Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway
    Gudrun Ulrich-Merzenich
    Medical Policlinic of the Rheinische, Friedrich Wilhelms University of Bonn, Wilhelmstr 35 37 53111 Bonn, Germany
    Eur J Nutr 46:87-94. 2007
    ..Large primary prevention trials failed to confirm this. Mechanistic studies may contribute to resolve this discrepancy...
  10. doi request reprint New perspectives for synergy research with the "omic"-technologies
    G Ulrich-Merzenich
    Medical Policlinic of the Rheinische Friedrich Wilhelms University of Bonn, Wilhelmstr 35 37, D 53111 Bonn, Germany
    Phytomedicine 16:495-508. 2009
    ....
  11. ncbi request reprint Application of the "-Omic-" technologies in phytomedicine
    G Ulrich-Merzenich
    Medical Policlinic of Rheinische Friedrich Wilhelms University of Bonn, Wilhelmstr 35 37, D 53111 Bonn, Germany
    Phytomedicine 14:70-82. 2007
    ..The application of the "-omic-" technologies may lead to a change of paradigms towards the application of complex mixtures in medicine and open the new field of phytogenomics, -proteomics and -metabolomics...
  12. ncbi request reprint [The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A]
    H Zeitler
    Medizinische Poliklinik der Universitat Bonn
    Dtsch Med Wochenschr 131:141-7. 2006
    ..Aim of an optimal treatment strategy should be to control bleedings by a rapid and safe elimination of the inhibitor and reinducing long-term immune tolerance...
  13. doi request reprint Genetic markers in acquired haemophilia
    J Oldenburg
    Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany
    Haemophilia 16:41-5. 2010
    ..17). This observation was mainly because of a higher frequency of the CTLA-4 + 49 G allele in female patients. These findings suggest that immune response genes may contribute to the development of anti-factor VIII autoantibodies in AH...
  14. ncbi request reprint Drug development from natural products: exploiting synergistic effects
    Gudrun Ulrich-Merzenich
    Medical Policlinic of the Rheinische Friedrich Wilhelms University of Bonn, Wilhelmstr 35 37, D 53111 Bonn, Germany
    Indian J Exp Biol 48:208-19. 2010
    ....
  15. doi request reprint Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling
    Gudrun Ulrich-Merzenich
    Medizinische Poliklinik der Rheinischen Friedrich Wilhelms Universität Bonn, Bonn, Germany
    Phytomedicine 16:2-16. 2009
    ..Their relevance in the treatment of various diseases is discussed in the context of a multitarget therapy with nutraceuticals and phytotherapeutic drugs...
  16. doi request reprint The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity
    Gudrun Ulrich-Merzenich
    University of Bonn, UKB Medical Clinic III, Sigmund Freud Str 25, Bonn, 53127, Germany
    Expert Opin Ther Targets 17:905-19. 2013
    ....
  17. ncbi request reprint Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls
    A Pavlova
    Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany
    Haemophilia 14:355-60. 2008
    ..In conclusion, on the background of the CTLA-4 gene polymorphism, further genetic and/or environmental factors might contribute to and finally trigger the clinical manifestation of AH...